Assembly Biosciences, Inc.
(NASDAQ : ASMB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
1.78%93.4618.6%$136.92m
AMRNAmarin Corporation Plc Sponsored ADR
10.79%19.312.0%$115.43m
SAGESAGE Therapeutics, Inc.
3.51%151.319.5%$74.40m
JAZZJazz Pharmaceuticals Plc
1.18%126.692.2%$72.83m
PRGOPerrigo Co. Plc
0.63%48.636.8%$61.23m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.03%151.206.3%$59.63m
CTLTCatalent Inc
1.01%42.972.4%$42.70m
PTLAPortola Pharmaceuticals, Inc.
1.73%30.677.7%$42.34m
ICLRICON Plc
2.01%145.004.1%$35.45m
CORTCorcept Therapeutics Incorporated.
3.25%11.455.5%$30.52m
HZNPHorizon Pharma plc
0.42%21.337.4%$29.76m
UTHRUnited Therapeutics Corporation
0.57%117.6914.4%$29.28m
MDCOMedicines Company
2.55%24.5121.8%$27.84m
AERIAerie Pharmaceuticals, Inc.
1.14%39.146.9%$26.82m
MNKMallinckrodt Plc
3.46%21.2321.1%$25.29m

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.